ANNA Bunn, Ph.D., Assistant Portfolio Manager for the Micro Cap Opportunities, Micro Cap, Global Health Care, and Biotechnology Sector strategies and Research Analyst. As a Research Analyst, Anna is responsible for selecting and monitoring securities within the health care sector of KCM’s universe. Anna joined KCM in January 2023 after gaining experience in equity analysis through the firm’s Biotechnology Equity Research Fellowship, a program she now manages at the firm. Anna graduated magna cum laude earning a B.A. in Neuroscience from The College of Wooster and a Ph.D. in Biology and Biomedical Sciences (Neuroscience) from Washington University. Anna’s doctoral research included both preclinical and clinical studies, with a focus on neuro-oncology.